相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Torsten Zuberbier et al.
ALLERGY (2022)
Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma
Chao Gu et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria
J. Castagna et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Factors related to omalizumab resistance in chronic spontaneous urticaria
Eli Magen et al.
ALLERGY AND ASTHMA PROCEEDINGS (2019)
Omalizumab chronic spontaneous urticaria Efficacy, safety, predictors of treatment outcome, and time to response
Eustachio Nettis et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model
Ninad Varkhede et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2018)
Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma
Maxime Luu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
分享论文
